Київська Медична Академія Післядипломної Освіти Ім. П.Шупика
Киевская Медицинская Академия Последипломного Образования Им. П.Л. Шупика
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Київська Медична Академія Післядипломної Освіти Ім. П.Шупика, Киевская Медицинская Академия Последипломного Образования Им. П.Л. ШупикаfiledCriticalКиївська Медична Академія Післядипломної Освіти Ім. П.Шупика
Priority to UA20040705333UpriorityCriticalpatent/UA4633U/en
Publication of UA4633UpublicationCriticalpatent/UA4633U/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
The method for treating the transitory posthypoxic ischemia of myocardium in the newborns comprises the use of bioflavonoids, namely quercetine. The drug is administered through the endogastral probe.
UA20040705333U2004-07-052004-07-05Method for treating transitory posthypoxic ischemia of myocardium in newborns
UA4633U
(en)
Use of compound genz-112638 (eliglustat), glucosylceramide synthase inhibitor, in the treatment of gaucher disease and fabry disease (divisional application 201201348).
Compounds derived from imidazo [1,2-a] pyridine; preparation procedure; pharmaceutical composition; intermediate compounds; and use in the treatment of cancer.
1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazine-6-carboxamide and 2,3,4,5-tetrahydropyrrolo(1,2-a)-diazepine-7-carboxamide derivatives, preparation and therapeutic use thereof